Home > Insider Trading > Amarin Corp Plc

Amarin Corp Plc (AMRN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
91 - 97

More Good News for Amarin Corporation plc (ADR) (AMRN): GlaxoSmithKline plc (ADR) (GSK)

Last year, a number of drugs received FDA approval. The drug authority has rolled out one approval after another, maybe to compensate for the patent cliff most large pharmaceuticals are facing.

Keep Reading →

March 14th, 2013 - News

5 "White Smoke" Stocks: Linn Energy LLC (LINE), Micron Technology, Inc. (MU), Sodastream International Ltd (SODA)

As cardinals gather to elect a new pope, the conclave uses a smokestack to communicate the deliberations.

Keep Reading →

March 14th, 2013 - News

Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)'s Fourth Quarter?

Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched its first drug, Vascepa...

Keep Reading →

March 6th, 2013 - News

3 Bio-Pharmaceuticals You Can't Ignore: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)

The last year has been a stellar one for the biotechnology industry.

Keep Reading →

February 26th, 2013 - News

A Buyout In Amarin Corporation plc (ADR) (AMRN) Is Imminent!

All throughout Wall Street we keep hearing about Amarin Corporation plc (ADR) (NASDAQ:AMRN) being bought out by some type of Big Pharma company in the future. It's all rumors circling around, but it...

Keep Reading →

February 22nd, 2013 - News

3 Horrendous Health-Care Stocks This Week: Accuray Incorporated (ARAY), Keryx Biopharmaceuticals (KERX)

OraSure Technologies, Inc. (NASDAQ:OSUR) announced its fourth-quarter results after the market closed on Wednesday. The oral fluid diagnostics maker beat analyst expectations by $0.03 per share.

Keep Reading →

February 9th, 2013 - News

Here’s What Tocqueville Asset Management Has Been Buying and Selling: Sarepta Therapeutics Inc (SRPT), Amarin Corporation plc (AMRN)

Today, let's look at Tocqueville Asset Management, which is a portfolio manager with a contrarian bent, believing that "the best investment results over time are achieved outside the mainstream consensus...

Keep Reading →

February 6th, 2013 - Hedge Funds